Literature DB >> 7590749

Chromosomal localization of the four genes (NFIA, B, C, and X) for the human transcription factor nuclear factor I by FISH.

F Qian1, U Kruse, P Lichter, A E Sippel.   

Abstract

Nuclear Factor I (NFI) proteins constitute a family of dimeric DNA-binding proteins with very similar, possibly identical, DNA-binding specificity. They function as cellular transcription factors and as replication factors for adenovirus DNA replication. Diversity in this protein family is generated by multiple genes, differential splicing, and heterodimerization. To determine the chromosomal position of NFI genes in the human genome, we isolated partial cDNA sequences derived from four independent genes: NFIA, NFIB, NFIC, and NFIX. Corresponding clones of genomic DNA served as probes for fluorescence in situ hybridization on human metaphase chromosomes. The NFIA and NFIB genes map to positions 1p31.2-p31.3 and 9p24.1, respectively. The NFIC and the NFIX genes were both localized to position 19p13.3 in the order centromere-NFIX-NFIC-telomere. Comparison of the position of NFI genes and JUN genes revealed a close physical linkage between members of the NFI and JUN gene families in the human genome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590749     DOI: 10.1006/geno.1995.1107

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  28 in total

1.  Expression, DNA-binding specificity and transcriptional regulation of nuclear factor 1 family proteins from rat.

Authors:  S Osada; T Matsubara; S Daimon; Y Terazu; M Xu; T Nishihara; M Imagawa
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

Review 2.  The Nuclear Factor I (NFI) gene family in mammary gland development and function.

Authors:  Janice Murtagh; Finian Martin; Richard M Gronostajski
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

3.  A novel 1p31.3p32.2 deletion involving the NFIA gene detected by array CGH in a patient with macrocephaly and hypoplasia of the corpus callosum.

Authors:  Udo Koehler; Elke Holinski-Feder; Birgit Ertl-Wagner; Juergen Kunz; Arpad von Moers; Hubertus von Voss; Chayim Schell-Apacik
Journal:  Eur J Pediatr       Date:  2009-09-08       Impact factor: 3.183

4.  ERα Binding by Transcription Factors NFIB and YBX1 Enables FGFR2 Signaling to Modulate Estrogen Responsiveness in Breast Cancer.

Authors:  Thomas M Campbell; Mauro A A Castro; Kelin Gonçalves de Oliveira; Bruce A J Ponder; Kerstin B Meyer
Journal:  Cancer Res       Date:  2017-11-27       Impact factor: 12.701

5.  Assignment of the porcine nuclear factor I/CTF (NFI/CTF) gene to chromosome 2q12-13 by FISH.

Authors:  L Frönicke; H Scherthan
Journal:  Mamm Genome       Date:  1997-06       Impact factor: 2.957

6.  NFIB is a potential target for estrogen receptor-negative breast cancers.

Authors:  Hyeong-Gon Moon; Ki-Tae Hwang; Jeong-Ah Kim; Hee Sung Kim; Min-Joo Lee; Eun-Mi Jung; Eunyoung Ko; Wonshik Han; Dong-Young Noh
Journal:  Mol Oncol       Date:  2011-08-08       Impact factor: 6.603

7.  Integrative modeling of transcriptional regulation in response to antirheumatic therapy.

Authors:  Michael Hecker; Robert Hermann Goertsches; Robby Engelmann; Hans-Juergen Thiesen; Reinhard Guthke
Journal:  BMC Bioinformatics       Date:  2009-08-24       Impact factor: 3.169

8.  Identification of O-linked N-acetylglucosamine (O-GlcNAc)-modified osteoblast proteins by electron transfer dissociation tandem mass spectrometry reveals proteins critical for bone formation.

Authors:  Alexis K Nagel; Michael Schilling; Susana Comte-Walters; Mary N Berkaw; Lauren E Ball
Journal:  Mol Cell Proteomics       Date:  2013-02-26       Impact factor: 5.911

9.  Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.

Authors:  Marta Persson; Ywonne Andrén; Joachim Mark; Hugo M Horlings; Fredrik Persson; Göran Stenman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

10.  Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours.

Authors:  J Mora; M Alaminos; C de Torres; P Illei; J Qin; N-K V Cheung; W L Gerald
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.